Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study.

Philpott CM, Smith R, Davies-Husband CR, Erskine S, Clark A, Welch A, Hopkins C, Carrie S, Ray J, Sunkaraneni V, Kara N, Kumar N, Robertson A, Anari S, Almeyda R, Wilson A.

Rhinology. 2019 Aug 1;57(4):303-312. doi: 10.4193/Rhin19.027.

PMID:
31120456
2.

Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.

Ebeyan S, Windsor M, Bordin A, Mhango L, Erskine S, Trembizki E, Mokany E, Tan LY, Whiley D; GRAND2 Study Investigators .

J Antimicrob Chemother. 2019 Jul 1;74(7):1820-1824. doi: 10.1093/jac/dkz108.

PMID:
30897201
3.

Eye movement desensitization and reprocessing as a treatment for tinnitus.

Phillips JS, Erskine S, Moore T, Nunney I, Wright C.

Laryngoscope. 2019 Jan 28. doi: 10.1002/lary.27841. [Epub ahead of print]

PMID:
30693546
4.

Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.

Philpott CM, Erskine S, Hopkins C, Kumar N, Anari S, Kara N, Sunkaraneni S, Ray J, Clark A, Wilson A; CRES group, Erskine S, Philpott C, Clark A, Hopkins C, Robertson A, Ahmed S, Kara N, Carrie S, Sunkaraneni V, Ray J, Anari S, Jervis P, Panesaar J, Farboud A, Kumar N, Cathcart R, Almeyda R, Khalil H, Prinsley P, Mansell N, Salam M, Hobson J, Woods J, Coombes E.

Respir Res. 2018 Jun 27;19(1):129. doi: 10.1186/s12931-018-0823-y.

5.

Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery.

Maniakas A, Desrosiers M, Asmar MH, Al Falasi M, Endam LM, Hopkins C, Philpott C, Erskine S, Smith R, Kilty S.

Rhinology. 2018 Jun 1;56(2):118-121. doi: 10.4193/Rhin17.165.

PMID:
29509831
6.

Travel Characteristics and Pretravel Health Care Among Pregnant or Breastfeeding U.S. Women Preparing for International Travel.

Hagmann SHF, Rao SR, LaRocque RC, Erskine S, Jentes ES, Walker AT, Barnett ED, Chen LH, Hamer DH, Ryan ET; Global TravEpiNet Consortium and the Boston Area Travel Medicine Network.

Obstet Gynecol. 2017 Dec;130(6):1357-1365. doi: 10.1097/AOG.0000000000002360.

7.

Current use of baseline medical treatment in chronic rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study (CRES).

Philpott C, Erskine S, Smith R, Hopkins C, Kara N, Farboud A, Salam M, Robertson A, Almeyda R, Kumar BN, Anari S, Ray J, Cathcart R, Carrie S, Ahmed S, Khalil H, Clark A, Thomas M; CRES group.

Clin Otolaryngol. 2018 Apr;43(2):509-524. doi: 10.1111/coa.13012. Epub 2017 Dec 11.

PMID:
29055085
8.

EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis.

Hellings PW, Akdis CA, Bachert C, Bousquet J, Pugin B, Adriaensen G, Advani R, Agache I, Anjo C, Anmolsingh R, Annoni E, Bieber T, Bizaki A, Braverman I, Callebaut I, Castillo Vizuete JA, Chalermwatanachai T, Chmielewski R, Cingi C, Cools L, Coppije C, Cornet ME, De Boeck I, De Corso E, De Greve G, Doulaptsi M, Edmiston R, Erskine S, Gevaert E, Gevaert P, Golebski K, Hopkins C, Hox V, Jaeggi C, Joos G, Khwaja S, Kjeldsen A, Klimek L, Koennecke M, Kortekaas Krohn I, Krysko O, Kumar BN, Langdon C, Lange B, Lekakis G, Levie P, Lourijsen E, Lund VJ, Martens K, Mő Sges R, Mullol J, Nyembue TD, Palkonen S, Philpott C, Pimentel J, Poirrier A, Pratas AC, Prokopakis E, Pujols L, Rombaux P, Schmidt-Weber C, Segboer C, Spacova I, Staikuniene J, Steelant B, Steinsvik EA, Teufelberger A, Van Gerven L, Van Gool K, Verbrugge R, Verhaeghe B, Virkkula P, Vlaminck S, Vries-Uss E, Wagenmann M, Zuberbier T, Seys SF, Fokkens WJ.

Rhinology. 2017 Sep 1;55(3):202-210. doi: 10.4193/Rhin17.028.

PMID:
28501885
9.

Health utility reporting in chronic rhinosinusitis patients.

Bewick J, Morris S, Hopkins C, Erskine S, Philpott CM.

Clin Otolaryngol. 2018 Feb;43(1):90-95. doi: 10.1111/coa.12903. Epub 2017 Jun 13.

PMID:
28498517
10.

Chronic rhinosinusitis and mood disturbance.

Erskine SE, Hopkins C, Clark A, Anari S, Robertson A, Sunkaraneni S, Wilson JA, Beezhold J, Philpott CM.

Rhinology. 2017 Jun 1;55(2):113-119. doi: 10.4193/Rhin16.111.

PMID:
28434016
11.

A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders.

Philpott CM, Erskine SE, Clark A, Leeper A, Salam M, Sharma R, Murty GE, Hummel T.

Clin Otolaryngol. 2017 Dec;42(6):1295-1302. doi: 10.1111/coa.12878. Epub 2017 Apr 17.

PMID:
28339165
12.

Management of pinna haematoma study (MaPHaeS): A multicentre retrospective observational study.

Vijendren A, Coates M, Smith ME, Ajayi OV, Al-Dhahir W, Bewick J, Bowles PF, Coyle P, Davies-Husband CR, Erskine SE, Halliday E, Kaleva AI, Lau A, Langstaff L, Mathew E, Meghji S, Testera A, Thomas JRV, Eisenhut M.

Clin Otolaryngol. 2017 Dec;42(6):1252-1258. doi: 10.1111/coa.12858. Epub 2017 Apr 4.

PMID:
28247538
13.

Characteristics of US Travelers to Zika Virus-Affected Countries in the Americas, March 2015-October 2016.

Lammert S, Walker AT, Erskine S, Rao SR, Esposito DH, Ryan ET, Robbins GK, LaRocque RC.

Emerg Infect Dis. 2017 Feb;23(2):324-327. doi: 10.3201/eid2302.161292. Epub 2017 Feb 15.

14.

Refusal of recommended travel-related vaccines among U.S. international travellers in Global TravEpiNet.

Lammert SM, Rao SR, Jentes ES, Fairley JK, Erskine S, Walker AT, Hagmann SH, Sotir MJ, Ryan ET, LaRocque RC.

J Travel Med. 2016 Oct 30;24(1). pii: taw075. Print 2016 Jul.

15.

A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes.

Erskine S, Hopkins C, Kumar N, Wilson J, Clark A, Robertson A, Kara N, Sunkaraneni V, Anari S, Philpott C.

Rhinology. 2016 Dec 1;54(4):311-315. doi: 10.4193/Rhin15.361.

PMID:
27315942
16.

The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis.

Bewick J, Ahmed S, Carrie S, Hopkins C, Sama A, Sunkaraneni V, Woods J, Morris S, Erskine S, Philpott CM.

Clin Otolaryngol. 2017 Feb;42(1):131-138. doi: 10.1111/coa.12685. Epub 2016 Jun 20.

PMID:
27223120
17.

A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis.

Philpott C, Erskine S, Hopkins C, Coombes E, Kara N, Sunkareneni V, Anari S, Salam M, Farboud A, Clark A; CRES Group.

Rhinology. 2016 Jun;54(2):134-40. doi: 10.4193/Rhin15.272.

PMID:
27172454
18.

SNOT-22 in a control population.

Erskine SE, Hopkins C, Clark A, Anari S, Kumar N, Robertson A, Sunkaraneni S, Wilson JA, Carrie S, Kara N, Ray J, Smith R, Philpott CM; CRES Group.

Clin Otolaryngol. 2017 Feb;42(1):81-85. doi: 10.1111/coa.12667. Epub 2016 Jun 9.

PMID:
27147284
19.

Quality-of-life outcomes after sinus surgery in allergic fungal rhinosinusitis versus nonfungal chronic rhinosinusitis.

Masterson L, Egro FM, Bewick J, Erskine SE, Clark A, Javer AR, Philpott CM.

Am J Rhinol Allergy. 2016 Mar-Apr;30(2):e30-5. doi: 10.2500/ajra.2016.30.4280.

PMID:
26980383
20.

EzyAmp signal amplification cascade enables isothermal detection of nucleic acid and protein targets.

Linardy EM, Erskine SM, Lima NE, Lonergan T, Mokany E, Todd AV.

Biosens Bioelectron. 2016 Jan 15;75:59-66. doi: 10.1016/j.bios.2015.08.021. Epub 2015 Aug 12.

21.

Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study.

Erskine SE, Verkerk MM, Notley C, Williamson IG, Philpott CM.

Clin Otolaryngol. 2016 Feb;41(1):8-14. doi: 10.1111/coa.12462.

PMID:
25974166
22.

The burden of revision sinonasal surgery in the UK-data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study.

Philpott C, Hopkins C, Erskine S, Kumar N, Robertson A, Farboud A, Ahmed S, Anari S, Cathcart R, Khalil H, Jervis P, Carrie S, Kara N, Prinsley P, Almeyda R, Mansell N, Sunkaraneni S, Salam M, Ray J, Panesaar J, Hobson J, Clark A, Morris S.

BMJ Open. 2015 Apr 29;5(4):e006680. doi: 10.1136/bmjopen-2014-006680.

23.

Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions.

Erskine SE, Notley C, Wilson AM, Philpott CM.

J Asthma. 2015;52(6):600-5. doi: 10.3109/02770903.2014.995308. Epub 2015 Jul 8.

PMID:
25539398
24.

Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models.

Stevenson JM, Williams JL, Burnham TG, Prevost AT, Schiff R, Erskine SD, Davies JG.

Clin Interv Aging. 2014 Sep 19;9:1581-93. doi: 10.2147/CIA.S65475. eCollection 2014. Review.

25.

The application and value of the 'T-14 tool' as a patient-reported outcome measure for paediatric tonsillectomy: a report on 45 cases.

Dawe N, Erskine S, Moor JW.

Clin Otolaryngol. 2015 Feb;40(1):41-4. doi: 10.1111/coa.12311. No abstract available.

PMID:
25200535
26.

DNA-only cascade: a universal tool for signal amplification, enhancing the detection of target analytes.

Bone SM, Hasick NJ, Lima NE, Erskine SM, Mokany E, Todd AV.

Anal Chem. 2014 Sep 16;86(18):9106-13. doi: 10.1021/ac501811r. Epub 2014 Aug 26.

PMID:
25157928
27.

Unilateral cacosmia: a presentation of maxillary fungal infestation.

Erskine SE, Schelenz S, Philpott CM.

BMJ Case Rep. 2013 Apr 5;2013. pii: bcr2013008808. doi: 10.1136/bcr-2013-008808.

28.

GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition.

Gilmartin AG, Bleam MR, Groy A, Moss KG, Minthorn EA, Kulkarni SG, Rominger CM, Erskine S, Fisher KE, Yang J, Zappacosta F, Annan R, Sutton D, Laquerre SG.

Clin Cancer Res. 2011 Mar 1;17(5):989-1000. doi: 10.1158/1078-0432.CCR-10-2200. Epub 2011 Jan 18. Erratum in: Clin Cancer Res. 2012 Apr 15;18(8):2413.

29.

Socioeconomic deprivation, urban-rural location and alcohol-related mortality in England and Wales.

Erskine S, Maheswaran R, Pearson T, Gleeson D.

BMC Public Health. 2010 Feb 25;10:99. doi: 10.1186/1471-2458-10-99.

30.

Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis.

Gilmartin AG, Bleam MR, Richter MC, Erskine SG, Kruger RG, Madden L, Hassler DF, Smith GK, Gontarek RR, Courtney MP, Sutton D, Diamond MA, Jackson JR, Laquerre SG.

Cancer Res. 2009 Sep 1;69(17):6969-77. doi: 10.1158/0008-5472.CAN-09-0945. Epub 2009 Aug 18.

31.

Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase.

Jarvest RL, Erskine SG, Forrest AK, Fosberry AP, Hibbs MJ, Jones JJ, O'Hanlon PJ, Sheppard RJ, Worby A.

Bioorg Med Chem Lett. 2005 May 2;15(9):2305-9.

PMID:
15837314
32.

DNA cleavage by the EcoRV restriction endonuclease: roles of divalent metal ions in specificity and catalysis.

Baldwin GS, Sessions RB, Erskine SG, Halford SE.

J Mol Biol. 1999 Apr 23;288(1):87-103.

PMID:
10329128
34.

Rapid-reaction analysis of plasmid DNA cleavage by the EcoRV restriction endonuclease.

Erskine SG, Baldwin GS, Halford SE.

Biochemistry. 1997 Jun 17;36(24):7567-76.

PMID:
9200708
35.

Refractive-index detection by interferometric backscatter in packed-capillary high-performance liquid chromatography.

Kenmore CK, Erskine SR, Bornhop DJ.

J Chromatogr A. 1997 Feb 21;762(1-2):219-25.

PMID:
9098980
36.

A general assay for restriction endonucleases and other DNA-modifying enzymes with plasmid substrates.

Vipond IB, Baldwin GS, Oram M, Erskine SG, Wentzell LM, Szczelkun MD, Nobbs TJ, Halford SE.

Mol Biotechnol. 1995 Dec;4(3):259-68.

PMID:
8680932
37.

Interactions of the EcoRV restriction endonuclease with fluorescent oligodeoxynucleotides.

Erskine SG, Halford SE.

Gene. 1995 May 19;157(1-2):153-6.

PMID:
7607481
38.

Fluorescent substrates for the EcoRV restriction endonuclease.

Erskine SG, Halford SE.

Biochem Soc Trans. 1994 Aug;22(3):299S. Review. No abstract available.

PMID:
7821558
39.

Specific rotation measurements from peak height data, with a Gaussian peak model.

Rice PD, Shao YY, Erskine SR, Teague TG, Bobbitt DR.

Talanta. 1989 Apr;36(4):473-8.

PMID:
18964741
41.

The anxiety disorders clinic.

Erskine SD.

New Dir Ment Health Serv. 1986 Winter;(32):81-97. No abstract available.

PMID:
3807874

Supplemental Content

Loading ...
Support Center